Results
7
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
7 companies
Cyclopharm
Market Cap: AU$122.3m
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally.
CYC
AU$1.10
7D
-6.8%
1Y
-38.4%
CardieX
Market Cap: AU$26.7m
Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.
CDX
AU$0.066
7D
6.5%
1Y
-9.6%
Pacific Smiles Group
Market Cap: AU$290.1m
Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.
PSQ
AU$1.80
7D
-6.8%
1Y
9.5%
Advanced Health Intelligence
Market Cap: AU$22.6m
Operates as a mobile application and technology development company in Australia and internationally.
AHI
AU$0.092
7D
0%
1Y
15.0%
ImExHS
Market Cap: AU$15.1m
Offers cloud-based medical imaging solutions in Australia and internationally.
IME
AU$0.33
7D
-5.7%
1Y
-40.0%
Alcidion Group
Market Cap: AU$99.4m
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
ALC
AU$0.074
7D
7.2%
1Y
68.2%
Nanosonics
Market Cap: AU$1.5b
Operates as an infection prevention company globally.
NAN
AU$4.82
7D
2.3%
1Y
67.9%